Advertisement

Psychopharmacologia

, Volume 2, Issue 1, pp 63–68 | Cite as

Withdrawal reactions from chlordiazepoxide (“Librium”)

  • Leo E. Hollister
  • Francis P. Motzenbecker
  • Roger O. Degan
Clinical Reports

Summary

Ten of 11 patients abruptly switched to placebos after several months of high daily doses (300–600 mg, 8–20 times the usual therapeutic range) of chlordiazepoxide experienced new symptoms and signs soon after. Depression, aggravation of psychoses, agitation, insomnia, loss of appetite, and nausea appeared between two and eight days following abrupt withdrawal. Two patients had seizures at seven and eight days. A third patient, not in the withdrawal study, had a seizure twelve days after discontinuation of a 300 mg daily dose. Plasma levels of drug indicated a half-life of approximately forty-eight hours following discontinuation of chronic high doses. Minor electroencephalographic abnormalities (mainly slowing) were produced by chronic administration of these exceedingly high doses. If large doses of chlordiazepoxide are used, the drug should not be abruptly discontinued.

Keywords

Placebo Depression Plasma Level Chlordiazepoxide Large Dose 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. English, D. C.: Librium, a new nonsedative neuroleptic drug: A clinical evaluation Curr. Ther. Res. 2 (3), 88–91 (1960).Google Scholar
  2. Harris, T. H.: Methaminodiazepoxide. J. Amer. med. Ass. 172, 1162–1163 (1960).Google Scholar
  3. Hollister, L. E., E. M. Caffey Jr. and C. J. Klett: Abnormal symptoms, signs and laboratory tests during treatment with phenothiazine derivatives. A controlled study. Clin. Pharm. and Ther. 1, 284 (1969a).Google Scholar
  4. Hollister, L. E., and F. S. Glazener: Withdrawal reactions from meprobamate, alone and combined with promazine: A controlled study. Psychopharmacologia 1, 336–341 (1960b).Google Scholar
  5. Kinross-Wright, J., I. M. Cohen and J. A. Knight: The management of neurotic and psychotic states with Ro 5-0690 (Librium). Dis. nerv. Syst. 21, Suppl. 3, 23–26 (1960).Google Scholar
  6. Randall, L. D.: Pharmacology of methaminodiazepoxide. Dis. nerv. Syst. 21, Suppl. 3, 7–10 (1960).Google Scholar
  7. Tobin, J. M., I. F. Bird and D. E. Boyle: Preliminary evaluation of Librium (Ro 5-0690) in the treatment of anxiety reactions. Dis. nerv. Syst. 21, Suppl 3, 11–19 (1960).Google Scholar

Copyright information

© Springer-Verlag 1961

Authors and Affiliations

  • Leo E. Hollister
    • 1
  • Francis P. Motzenbecker
    • 1
  • Roger O. Degan
    • 1
  1. 1.Veterans Administration HospitalPalo Alto

Personalised recommendations